What is MK-677 studied for?

Published and ongoing research looks at sustained IGF-1 elevation and lean-mass increase in trials; sleep architecture; bone density and nitrogen balance in older adults. These are areas of study, not promised outcomes.

Is MK-677 FDA-approved?

MK-677 has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.

How is MK-677 typically used?

Oral, once daily — the reason it stays popular despite the drawbacks Appetite increase is pronounced and often the dominant effect Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.

What are the risks and unknowns with MK-677?

Not FDA-approved; research use only Documented reductions in insulin sensitivity and increases in fasting glucose Water retention, lethargy and elevated cortisol reported in trials One trial in a frail elderly population was stopped over heart-failure signals — this is not a casual compound

Growth hormone secretagogues

MK-677

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending.

Also known as Ibutamoren

An orally active, non-peptide ghrelin-receptor agonist studied for sustained GH and IGF-1 elevation.

What it is

MK-677 is a small molecule, not a peptide, that mimics ghrelin at its receptor and raises GH and IGF-1 for roughly 24 hours per dose. It reached late-stage clinical trials and was never approved; its long half-life is both its appeal and the source of most of its problems.

What it's studied for

Sustained IGF-1 elevation and lean-mass increase in trials
Sleep architecture
Bone density and nitrogen balance in older adults

How it's used in practice

Oral, once daily — the reason it stays popular despite the drawbacks
Appetite increase is pronounced and often the dominant effect

What you should know before asking about it

Not FDA-approved; research use only
Documented reductions in insulin sensitivity and increases in fasting glucose
Water retention, lethargy and elevated cortisol reported in trials
One trial in a frail elderly population was stopped over heart-failure signals — this is not a casual compound

Frequently asked questions.

What is MK-677?: MK-677 is a small molecule, not a peptide, that mimics ghrelin at its receptor and raises GH and IGF-1 for roughly 24 hours per dose. It reached late-stage clinical trials and was never approved; its long half-life is both its appeal and the source of most of its problems.
What is MK-677 studied for?: Published and ongoing research looks at sustained IGF-1 elevation and lean-mass increase in trials; sleep architecture; bone density and nitrogen balance in older adults. These are areas of study, not promised outcomes.
Is MK-677 FDA-approved?: MK-677 has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
How is MK-677 typically used?: Oral, once daily — the reason it stays popular despite the drawbacks Appetite increase is pronounced and often the dominant effect Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
What are the risks and unknowns with MK-677?: Not FDA-approved; research use only Documented reductions in insulin sensitivity and increases in fasting glucose Water retention, lethargy and elevated cortisol reported in trials One trial in a frail elderly population was stopped over heart-failure signals — this is not a casual compound

Sources

1.Published literature on MK-677 Ibutamoren— PubMed, U.S. National Library of Medicine
2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
4.Test directory and patient service center locator— Quest Diagnostics

About this page

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.

This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.

Begin your intake Peptide therapy overview